Sugi Predict

Sugi Predict / Compounds / SCHEMBL23333349

SCHEMBL23333349

SCHEMBL23333349

CCCCCc1cc(F)c(C#Cc2ccc(N=Nc3ccc(OCCC)cc3)cc2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 11/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SLCO1B3 Q9NPD5 1/20 0.38
▸ SLCO1B1 Q9Y6L6 1/20 0.38
▸ PPARA Q07869 2/20 0.35
▸ PPARG P37231 1/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ RARA P10276 1/20 0.34
▸ RARB P10826 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29306142 0.99 MEN1 (0.39) ACACBMEN1USP2ALDH1A1LMNA
SCHEMBL29306143 0.98 LMNA (0.38) ACACBMEN1USP2ALDH1A1LMNA
SCHEMBL23333353 0.96 ACACB (0.41) ACACBPPARAPPARGCYP2C9CYP1A2
SCHEMBL29306134 0.95 ACACB (0.38) ACACBMEN1USP2ALDH1A1LMNA
SCHEMBL29306133 0.95 ACACB (0.39) ACACBMEN1USP2ALDH1A1LMNA
SCHEMBL29306141 0.93 MAPT (0.40) ACACBMEN1ALDH1A1MAPK1KMT2A
SCHEMBL29306139 0.93 ACACB (0.38) ACACBLMNAPPARACYP2C9CYP1A2
SCHEMBL29306138 0.93 ACACB (0.39) ACACBPPARAPPARGCYP2C9CYP1A2
SCHEMBL29306137 0.92 ACACB (0.43) ACACBLMNAPPARACYP2C9
SCHEMBL29306140 0.91 PTGS2 (0.39) ACACBMEN1ALDH1A1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 — — US disclosed
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME DIC CORPORATION (JP) 2024-07-11 — — US disclosed
WO-2021085280-A1 LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION DEVICE, AND ANTENNA DIC株式会社 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228878-A1 COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME TTI2, CCT4, CCT2 ACACB 1767/4885MEN1 2827/4885USP2 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.